French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...
Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Just a few weeks ...
After the successful separation of a monolayer of carbon atoms with honeycomb lattice known as graphene in 2004, a large group of 2D materials known as TMDCs and MXenes were discovered and studied.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback